Polaris Market Research recently published a research report titled, “Colorectal Cancer Market, [by Therapy (Radiation Therapy, Chemotherapy, Targeted Therapy, Surgery, Others); by Drug Type (Bevacizumab (Avastin), Cetuximab (Erbitux), Panitumumab (Vectibix), Regoraferin (Stivarga), Ziv-Aflibrcept (Zaltrap), TAS-10 (Lonsurf), Others); by Diagnostics (Digital Rectal Examination,...
0 Commentarios
0 Acciones
1103 Views
0 Vista previa
"According to the research report, the global colorectal cancer market was valued at USD 1.90 billion in 2023 and is expected to reach USD 2.88 billion by 2032, to grow at a CAGR of 4.80% during the forecast period."
The Colorectal Cancer Market 2024: By Types, Applications, Size, Share, Key Players & Regions Forecast Analysis till 2032 from Polaris Market Research offers an...
0 Commentarios
0 Acciones
179 Views
0 Vista previa